You have free access to this content

Hepatocyte growth factor twenty years on: Much more than a growth factor

Takahiro Nakamura¹,
Katsuya Sakai¹,
Toshikazu Nakamura²,
Kunio Matsumoto^1,*

Article first published online: 4 JAN 2011

DOI: 10.1111/j.1440-1746.2010.06549.x

Issue

Journal of Gastroenterology and Hepatology

Special Issue: Silver Jubilee Supplement: Celebrating 25 years of JGH

Volume 26, Issue Supplement s1, pages 188–202, January 2011

Additional Information

How to Cite

Nakamura, T., Sakai, K., Nakamura, T. and Matsumoto, K. (2011), Hepatocyte growth factor twenty years on: Much more than a growth factor. Journal of Gastroenterology and Hepatology, 26: 188–202. doi: 10.1111/j.1440-1746.2010.06549.x

Author Information

¹
Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Japan
²
Kringle Pharma Joint Research Division for Regenerative Drug Discovery, Center for Advanced Science and Innovation, Osaka University, Suita, Osaka, Japan

^*Dr. Kunio Matsumoto, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan. Email: kmatsu@staff.kanazawa-u.ac.jp

Conflict of interest KM has acted as a Cheif Scientific officer and own stocks in Kringle Pharma, Inc.

Publication History

Issue published online: 4 JAN 2011
Article first published online: 4 JAN 2011

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1652K)

References

1
Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 1984; 122: 1450–9.
2
Russell WE, McGowan JA, Bucher NL. Partial characterization of hepatocyte growth factor from rat platelets. J. Cell. Physiol. 1984; 1190: 183–92.
Direct Link:
3
Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987; 224: 311–8.
4
Gohda E, Tsubouchi H, Nakayama H et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 1988; 88: 414–9.
- CrossRef,
- Web of Science® Times Cited: 564
5
Zarnegar R, Michalopoulos GK. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 1989; 49: 3314–20.
6
Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989; 342: 440–3.
7
Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 1989; 163: 967–73.
8
Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J. Gastroenterol. Hepatol. 1991; 6: 509–19.
Direct Link:
9
Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239–42.
10
Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interaction and movement. Proc. Natl. Acad. Sci. USA. 1989; 86: 5844–8.
11
Weidner KM, Behrens J, Vanderkerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 1990; 111: 2097–108.
12
Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802–4.
13
Naldini L, Vigna E, Narcimham RP et al. Hepatocyte growth factor stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991; 6: 501–4.
14
Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901–8.
15
Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A, Higashio K. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem. Biophys. Res. Commun. 1991; 180: 1151–8.
16
Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and for potent anti-hepatitis action in vivo. Hepatology 1992; 16: 1227–35.
17
Schmidt C, Bladt F, Goedecke S et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699–702.
18
Uehara Y, Minowa O, Mori C et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702–5.
19
Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995; 376: 768–71.
20
Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. 1995; 118: 643–49.
21
Schmidt L, Duh F, Chan F et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 1997; 16: 68–73.
22
Ultsch M, Lokker NA, Godowski PJ, de Vos AM. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. Structure 1998; 6: 1383–93.
23
Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 1998; 17: 3045–54.
24
Chirgadze DY, Hepple JP, Zhou H, Byrd RA, Blundell TL, Gherardi E. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat. Struct. Biol. 1999; 6: 72–9.
25
Nayeri F, Strömberg T, Larsson M, Brudin L, Söderström C, Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. J. Dermatolog. Treat. 2002; 13: 81–6.
26
Schiering N, Knapp S, Marconi M et al. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a. Proc. Natl. Acad. Sci. USA. 2003; 100: 12654–9.
27
Stamos J, Lazarus RA, Yao X, Kirchhofer D, Wiesmann C. Crystal structure of the HGF β-chain in complex with the Sema domain of the Met receptor. EMBO J. 2004; 23: 2325–35.
28
Morishita R, Aoki M, Hashiya N et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203–9.
29
Shigematsu H, Yasuda K, Iwai T et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010; 17: 1152–61.
30
Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 1998; 8: 404–9.
31
Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci. 1999; 2: 213–17.
32
Ebens A, Brose K, Leonard ED et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and neurotrophic factor for spinal motor neurons. Neuron 1996; 17: 1157–72.
33
Ohya W, Funakoshi H, Kurosawa T, Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res. 2007; 1147: 51–65.
34
Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 1996; 119: 591–600.
35
Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Hepatocyte growth factor abrogates Fas-induced lethal liver apoptosis in mice. Biochem. Biophys. Res. Commun. 1998; 244: 683–90.
36
Kim WH, Matsumoto K, Bessho K, Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am. J. Pathol. 2005; 166: 1017–28.
37
Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA. 2004; 101: 4477–82.
38
Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. USA. 2004; 101: 10608–13.
39
Giebeler A, Boekschoten MV, Klein C et al. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 2009; 137: 297–308.
40
Ma H, Saenko M, Opuko A et al. Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction. Kidney Int. 2009; 76: 868–76.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
41
Dai C, Saleem MA, Holzman LB, Mathieson P, Liu Y. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int. 2010; 77: 962–73.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
42
Chmielowiec J, Borowiak M, Morkel M et al. Birchmeier W. c-Met is essential for wound healing in the skin. J. Cell Biol. 2007; 177: 151–62.
43
Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 2005; 54: 2090–102.
44
Dai C, Huh CG, Thorgeirsson SS, Liu Y. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am. J. Pathol. 2005; 167: 429–36.
45
Takami T, Kaposi-Novak P, Uchida K et al. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Res. 2007; 67: 9844–51.
46
Marx-Stoelting P, Borowiak M, Knorpp T, Birchmeier C, Buchmann A, Schwarz M. Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met. Int. J. Cancer 2009; 124: 1767–72.
Direct Link:
47
Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 1993; 268: 10024–8.
48
Miyazawa K. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J. 2010; 277: 2208–14.
Direct Link:
49
Kataoka H, Kawaguchi M. Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo. FEBS J. 2010; 277: 2230–7.
Direct Link:
50
Itoh H, Naganuma S, Takeda N et al. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 2004; 127: 1423–35.
51
Marchand-Adam S, Fabre A, Mailleux AA et al. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 58–66.
52
Okunishi K, Dohi M, Nakagome K et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 2005; 175: 4745–53.
53
Rutella S, Bonanno G, Procoli A et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10⁺⁺IL-12^low/neg accessory cells with dendritic-cell features. Blood 2006; 108: 218–27.
54
Benkhoucha M, Santiago-Raber ML, Schneiter G et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2010; 107: 6424–9.
55
Ponzetto C, Bardelli A, Zhen Z et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 1994; 77: 261–71.
56
Sachs M, Brohmann H, Zechner D et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 2000; 150: 1375–84.
57
Peschard P, Fournier TM, Lamorte L et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 2001; 8: 995–1004.
58
Gandino L, Longati P, Medico E, Prat M, Comoglio PM. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 1994; 269: 1815–20.
59
Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J. Biol. Chem. 2004; 279: 26445–52.
60
Matsumoto K, Kataoka H, Date K, Nakamura T. Cooperative interaction between α-chain and β-chain of HGF on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J. Biol. Chem. 1998; 273: 22913–20.
61
Wang W, Marimuthu A, Tsai J et al. Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase. Proc. Natl. Acad. Sci. USA. 2006; 103: 3563–8.
62
Matsumoto K, Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 1994; 269: 31807–13.
63
Matsumoto K, Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer 2006; 119: 477–83.
Direct Link:
64
Jeffers M, Schmidt L, Nakagawa N et al. Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA. 1997; 94: 11445–50.
65
Cipriani NA, Abidoye OO, Vokes E, Salgia R. MET as a target for treatment of chest tumors. Lung Cancer 2009; 63: 169–79.
66
Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat. Rev. Drug Discov. 2008; 7: 504–16.
67
Sattler M, Salgia R. The MET axis as a therapeutic target. Update Cancer Ther. 2009; 3: 109–18.
68
Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T. HGF/NK4 is a specific antagonist for pleiotropic actions of hepatocyte growth factor. FEBS Lett. 1997; 420: 1–6.
69
Nakamura T, Sakai K, Nakamura T, Matsumoto K. Anticancer approach with NK4: bivalent action and mechanisms. Anticancer Agents Med. Chem. 2010; 10: 36–46.
70
Sakai K, Nakamura T, Matsumoto K, Nakamura T. Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association. J. Biol. Chem. 2009; 284: 22491–9.
71
Naka K, Hoshii T, Muraguchi T et al. TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010; 463: 676–80.
72
Tamase A, Muraguchia T, Naka K et al. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc. Natl. Acad. Sci. USA. 2009; 106: 17163–8.
73
Engelman JA, Zejnullahu K, Mitsudomi T et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007; 316: 1039–43.
74
Yano S, Wang W, Li Q et al. Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with EGF Receptor activating mutations. Cancer Res. 2008; 68: 6479–87.

View Full Article (HTML) Get PDF (1652K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Hepatocyte growth factor twenty years on: Much more than a growth factor

Journal of Gastroenterology and Hepatology

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Hepatocyte growth factor twenty years on: Much more than a growth factor

Journal of Gastroenterology and Hepatology

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this